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Nonenzymatic  Galactosylation of Human  Serum  Albumin 
IN VITRO PREPARATION* 
(Received for publication,  August 25, 1981) 
Joseph C. Urbanowski,  Menashi A. Cohenford, and Joel A. Dain$ 
From  the  Department of Biochemistry and  Biophysics, University of Rhode  Island, Kingston, Rhode  Island 02881 
Incubation  of  purified  human  serum  albumin with D- 
[~-‘~C]galactose (5 mM) or ~-[ l - ’~C]glu~ose  (5 m ~ )  in 
vitro for 7 days under physiological  conditions resulted 
in the time-dependent accumulation of radioactivity 
into trichloroacetic acid-precipitable material. Com- 
parative studies indicated that the rate of sugar incor- 
poration into albumin increased with increasing pH 
and temperature of incubation and followed a first 
order dependence with regard  to  monosaccharide  and 
albumin concentrations.  The extent of nonenzymatic 
galactosylation  of  human albumin was  approximately 
300% greater than the  extent of nonenzymatic glucosyl- 
ation under equivalent  experimental  conditions. Pro- 
longed dialysis  of the modified  albumins against a large 
excess of the unlabeled monosaccharides  failed to alter 
the amount of protein-bound radiolabeled carbohy- 
drate, suggesting that the linkage between  sugar and 
albumin is covalent in nature. The post-translational 
modification  of proteins by  nonenzymatic  galactosyla- 
tion  may be of physiological  significance in individuals 
with reduced  galactokinase or galactose-1-phosphate 
uridyl transferase activities. 
The increasing amount of reports with regard to the non- 
enzymatic incorporation of glucose into proteins, including 
lens crystdins (1-4), insulin ( 3 ,  basic myelin protein (6), 
erythrocyte  membrane  proteins (7, 8), collagen (9-ll), albu- 
min (12-15), immunoglobulins (13, 14), and hemoglobin (16- 
20), has encouraged speculation upon the significance of this 
phenomenon as concerns the pathophysiology of certain dis- 
orders of carbohydrate metabolism (3, 5, 16,  21-24). Chronic 
hyperglycemia, found in many diabetic individuals, enhances 
this type of post-translational  protein modification. For ex- 
ample, quantities of hemoglobin AIc, a nonenzymatically glu- 
cosylated form of hemoglobin A, parallel blood glucose con- 
centration (25-27). In addition, the nonenzymatic glycosyla- 
tion of lens crystallins is implicated in the etiology of both 
diabetic and galactosemic cataracts (1, 2,  28,  29). 
It has been suggested that  the clinical sequelae of diabetes 
may accrue from alterations in protein function occurring as 
a  result of glucose-dependent chemical modification (3). At 
the present time, the relationship between elevated tissue 
galactose concentrations and observed pathological compli- 
cations  in galactosemic patients remains obscure. However, 
we suggest that  the hypothesis offered for diabetes  may also 
be applied regarding galactosemia. 
* This work was supported in part by United  States Public Health 
Service Research Grant NS05104. The costs of publication of this 
article  were  defrayed  in part by the  payment of page  charges. This 
article must  therefore be  hereby marked  “aduertisernent” in  accord- 
ance  with 18 U.S.C. Section 1734 solely to indicate this  fact. * To whom all correspondence  should  be  addressed. 
We present here a preliminary report of the nonenzymatic 
galactosylation of human serum albumin in vitro, and in 
addition, we demonstrate that human albumin incorporates 
galactose both  faster and more extensively than glucose under 
various experimental conditions. A partial description has 
already appeared (30). 
EXPERIMENTAL  PROCEDURES 
Materials-Human serum was obtained fresh from the University 
of Rhode Island Health  Center (Kingston, RI).  Human serum  albumin 
was purified from  fresh human serum by affinity chromatography on 
AB-Gel blue (Bio-Rad) (31), followed by gel filtration on Bio-Gel P- 
150 (Bio-Rad) prior to recrystallization (32). D-Galactose and D-glu- 
cose were purchased  from  Sigma. ~-[l-’~C]Galactose (6.2 mCi/mmol) 
was obtained  from New England  Nuclear, ~-[ l -~~C]Glucose (5.8mCi/ 
mmol) was purchased  from International Chemical and Nuclear. Both 
chemical and radiochemical punty of the labeled sugars was assured 
at greater than 99% by the manufacturers; subsequent chromato- 
graphic and radiographic analysis in our laboratory confirmed the 
integrity of the tracers. 
Incubations-All solutions and materials were sterilized by auto- 
claving or by ultrafitration prior to incubation at  37 ”C in  a  shaking 
water bath. Sodium azide (0.0270) was added to prevent bacterial 
growth. Unless  indicated  otherwise, human  albumin solutions (10 mg/ 
m l )  were prepared in Dulbecco’s phosphate-buffered saline, pH 7.4 
(33). containing either galactose or glucose at  a concentration of 5 
mM. Trace amounts of the radiolabeled sugars were added to the 
mixtures to  obtain desired specific activity. 
Assays-Protein-bound radioactivity was measured  by removing 
0.04-ml aliquots of incubation  mixtures to 0.05 ml of a bovine serum 
albumin solution (10 mg/ml) and precipitating with 1.0 ml of cold 10% 
trichloroacetic acid. The mixtures were then centrifuged  in an  Eppen- 
dorf model 5412 Microfuge, and  the pellets were washed twice with 
1.0 ml of cold 10% trichloroacetic  acid. Precipitates were dissolved in 
0.5 ml of Protosol  (New  England Nuclear)  and counted for radioac- 
tivity  in Aquasol-2 (New England  Nuclear). Protein was assessed by 
the  method of Lowry et  al. (34) with human serum  albumin  serving 
as  the  standard. 
RESULTS 
Fig. 1 compares the incorporation of radionuclide into acid- 
precipitable material upon reaction of purified human serum 
albumin with either D-[l-14C]gdaCtOSe or D-[1-14C]glUCOSe. 
Protein accumulation of radioactivity followed a  rectangular 
hyperbola with increasing incubation for 7 days, at which time 
approximately 1.6  mol of galactose or 0.5 mol of glucose  was 
incorporated per mol of albumin. Despite the equivalence of 
reaction conditions, both the initial velocity and the degree of 
association of radionuclide with acid-precipitable material 
were significantly greater when galactose was employed rela- 
tive to when glucose was substituted in the incubations. It 
should be noted that chromatography of a hydrolysate of 
albumin, obtained at 7 days from the incubation with galac- 
tose, described in Fig.  1, resulted  in the recovery of radiolabel 
in both galactose and talose in  a  ratio of 3:l. The observation 
is not unexpected since the proposed reaction mechanism 
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112 Galactose-Albumin Adducts 
involving an Amadori rearrangement to the ketoamine adduct 
would destroy the chiral center at C-2 of galactose. Conse- 
quently, both galactose and talose should be obtained upon 
protein hydrolysis. This experiment strongly suggests that 
galactose, and not an alleged radiolysis contaminant (35), is 
indeed the modifying agent of albumin, at least with concern 
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FIG. 1. In vitro incorporation of D-[1-‘*C]galactose or D-[l- 
‘*C]glucose into human serum albumin. Albumin solutions (10 
mg/ml) were prepared in 1 ml of Dulbecco’s phosphate-buffered 
saline (33) containing 1 I.rCi of either o-[I-‘“Clgalactose or D-[I-‘“C] 
glucose and 5 mM of either D-galactose or D-&COSe, respectively. 
Incubations proceeded aseptically at 37 “C in a shaking water bath. 
Aliquots were removed at indicated times, and radioactivity precipi- 
table by trichloroacetic acid was determined as described under 
“Experimental Procedures.” 
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FIG. 2. In vitro incorporation of n-[l-‘%]galactose into hu- 
man serum albumin incubated with increasing concentrations 
of galactose. Albumin solutions (10 mg/ml) were prepared in 1 ml 
of Dulbecco’s phosphate-buffered saline (33) containing various con- 
centrations of D-g&CtOSe (2-20 mM) and D-[1-‘4C]galactose to a 
constant specific activity of 4.44 x 105 cpm/pmol. Incubation pro- 
ceeded at 37 “C in a shaking water bath for 24 h. Protein-bound 
radioactivity was determined as described under “Experimental Pro- 
cedures.” 
Ov,, IO0 15.0 20.0 
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FIG. 3. In uitro incorporation Of D-[1-‘4’C]ghCOSe into human 
serum albumin incubated with increasing concentrations of 
glucose. Albumin solutions (10 mg/ml) were prepared in 1 ml of 
Dulbecco’s phosphate-buffered saline (33) containing various concen- 
trations of D-&COSe (2-20 mM) and D-[1-“Clglucose to a constant 
specific activity of 4.44 x IO” cpm/pmoI. Incubation proceeded at 
37 “C in a shaking water bath for 24 h. Protein-bound radioactivity 
was determined aa described under “Experimental Procedures.” 
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Oi 50 
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FIG. 4. In vitro incorporation of n-[1-“Clgalactose into hu- 
man serum albumin incubated with increasing concentrations 
of protein. Albumin solutions (IO-50 mg/ml) were prepared in 1 ml 
of Dulbecco’s phosphate-buffered saline (33) containing I &i of D-[I- 
‘*C]galactose and 5 mM D-galactose. Incubation proceeded at 37 “C in 
a shaking water bath for 24 h. Protein-bound radioactivity was 
determined as described under “Experimental Procedures.” 
to the research here described. In addition, the ratio of galac- 
tose to talose, 3:1, compares favorably with the ratio of glucose 
to mannose, 3:1, obtained upon hydrolysis of hemoglobin AK 
(21). 
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FIG. 5. In vitro incorporation O f  D-[l-’4C]glUCOSe into  human 
serum albumin incubated  with  increasing  concentrations of 
protein. Albumin  solutions (10-50 mg/ml)  were  prepared in 1 ml of 
Dulbecco’s phosphate-buffered saline (33) containing 1 pCi of D-[1- 
C]glucose  and 5 mM D-glucose.  Incubation  proceeded at 37 “C in a 
shaking  water  bath  for 24 h. Protein-bound  radioactivity was deter- 
mined as described  under  “Experimental  Procedures.” 
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FIG. 6. Nonenzymatic  glycosylation of human  serum  albu- 
min in vitro as a function of pH. Albumin  solutions (10 mg/ml) 
were  prepared  in 1 ml of Dulbecco’s phosphate-buffered  saline (33) 
modified to  contain 15 times the usual  concentration of phosphate so 
as to  stabilize the reactions at the pH values  indicated.  Incubations 
contained 5 mM of either D-galactose  or  D-glucose  and 1 pCi  of either 
D-[l-“C]galactose  or  D-[l”4c]glUCOSe,  respectively,  and  were  allowed 
to proceed at 37 “C in a shaking  water  bath  for 24 h. Protein-bound 
radioactivity  was  determined  as  described  under  “Experimental Pro- 
cedures.”  Data  are  expressed  as  trichloroacetic  acid-precipitable 
counts  per  min in total incubation. 
We decided  next to  compare  the nonenzymatic  galactosyl- 
ation  and  the nonenzymatic glucosylation of human  albumin 
in vitro with  regard to  both  the  extent  and  the  rate of protein 
incorporation of monosaccharide as a function of various 
reaction conditions. Figs. 2 through 7 inclusive depict data 
concerning  several of the kinetic and  thermodynamic  proper- 
ties of albumin glycosylation in vitro. For example, the  rate of 
incorporation of both galactose (Fig. 2) and glucose (Fig. 3) 
increased  linearly  with  increasing concentration of the sugar; 
however, despite  the equivalence of reaction  conditions, non- 
enzymatic galactosylation occurred significantly faster  than 
nonenzymatic glucosylation. Similarly,  when protein glycosyl- 
ation occurred  in the presence of augmented  concentrations 
of albumin, the  linear increase  in the  rate of nonenzymatic 
galactosylation  (Fig. 4) was  again substantially  greater  than 
any  comparative increase  in the  rate of glucose incorporation 
(Fig. 5 )  even though identical reaction conditions were em- 
ployed. The  experimental  results described in Figs. 2 to 5 are 
not surprising, since the reaction mechanism would suggest 
that  the initial rate of albumin glycosylation in vitro is first 
order with  regard to  both  protein  and  sugar  concentrations 
separately  and second order overall. 
Additionally, we attempted  to  make a comparison of the 
rates of nonenzymatic  galactosylation and nonenzymatic glu- 
cosylation of human serum albumin in vitro under various 
conditions of pH  and  temperature. As shown  in Figs. 6 and 7, 
protein  incorporation of monosaccharide  increased  with both 
increasing pH  and increasing temperature of incubation,  re- 
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FIG. 7. Nonenzymatic glycosylation of human  serum  albu- 
min in vitro as a  function of temperature. Albumin  solutions (10 
mg/ml) were prepared in 1 ml of Dulbecco’s phosphate-buffered 
saline (33) and  contained 5 m~ of either D-galactose  or  D-glucose and 
1 pCi of either D-[l-’4C]galactose or D-[1-’4C]glUCOSe, respectively. 
Incubations  proceeded at the indicated  temperatures  for 24 h, after 
which  protein-bound  radioactivity  was  determined  as  described  under 
“Experimental Procedures.” Data are expressed as trichloroacetic 
acid-precipitable  counts  per  min  in total incubation. 
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114 Galactose-Albumin  Adducts 
spectively. Once again, the modification of human albumin by 
galactose exceeded the protein  alteration occurring when glu- 
cose  was substituted  in the reaction mixtures. 
Finally, it must be emphasized that in all of the experimen- 
tal circumstances described in  Figs. 2 to 7 inclusive, the  rate 
of nonenzymatic galactosylation of human albumin in vitro 
was consistently 4-fold greater than  the  rate of nonenzymatic 
glucosylation despite the  apparent identity of reaction envi- 
ronments. 
DISCUSSION 
Evidence for the nonenzymatic incorporation of glucose into 
proteins, both in uiuo and in uitro, is overwhelming (1-20), 
and it has been postulated that the enhancement of this 
phenomenon in  diabetes may contribute to  the pathophysi- 
ology of the disorder (e.g. atherosclerotic and microangio- 
pathic vascular disease and neuropathy) (3, 5, 16, 21-24). 
Working from this hypothesis we suggested that  the elevated 
tissue galactose concentrations and  the accompanying patho- 
logical complications in galactosemia may be partially  related 
through the nonenzymatic galactosylation of proteins in uiuo. 
Accordingly, we decided to examine the nonenzymatic incor- 
poration of galactose into serum proteins in uitro, and  the 
results of this study  have been presented here. 
Additional experiments enabled us to demonstrate that  the 
rate of protein glycosylation in uitro followed a fist order 
dependence with regard to monosaccharide (Figs. 2 and 3) 
and albumin (Figs. 4  and 5) concentrations  and increased with 
increasing pH (Fig. 6)  and temperature (Fig. 7) of reaction. 
The major finding of this  report, however, consists of the 
observation that galactose nonenzymatically glycosylates hu- 
man  serum albumin in uitro, both faster and more extensively 
than glucose, under  apparently equivalent incubation condi- 
tions (Figs. 1-7). Reasons for this behavior are not readily 
evident. Nevertheless, we can speculate that  the greater gen- 
eral instability of galactose relative to glucose might render 
the former more vulnerable to nucleophilic attack by appro- 
priately reactive groups on the protein. In fact, Kelly (36) has 
documented the approximately 2-fold greater instability of 
the preferred conformation of galactose, compared to the 
preferred conformation of glucose, as resulting from an axial 
orientation of the hydroxyl group on the fourth carbon of 
galactose. We may suppose that  the ensuing steric  hindrance 
could cause the generation of a higher percentage of the 
chemically more reactive straight-chain form of the sugar  (37). 
Our conjecture is an adequate  interpretation for the observed 
differences in the initial rates of nonenzymatic galactosylation 
and glucosylation of human serum albumin. However, the 
disparity in the overall extent of protein incorporation of 
galactose and glucose remains to be explained. In spite of this, 
we believe it is possible that,  just  as certain sugars are more 
chemically reactive relative to one another,  certain groups on 
the protein may possess various levels of reactivity, especially 
where specific monosaccharides are concerned. In  other 
words, it is plausible that  there may exist some measure of 
distinctness between protein galactosylation sites and protein 
glucosylation sites, which might account for the observed 
disparity regarding incorporation of certain sugars. It should 
be mentioned that Dolhofer and Wieland (5) also noticed a 
difference in both the initial rates and the final extent of 
nonenzymatic incorporation of mannose and glucose into in- 
sulin, with the former combining both faster and  to a  greater 
degree. Again, according to Kelly (36), the preferred confor- 
mation of mannose is significantly more unstable  in compari- 
son to that of glucose, due to  the presence of an axial hydroxyl 
group on the second carbon  atom of the mannopyranose ring. 
It is conceivable that the galactose-dependent chemical 
modification of proteins in uiuo might alter  both their  rate 
and their path of metabolism, in addition to their proper 
functioning in the body. For example, the nonenzymatic ga- 
lactosylation of albumin may affect its ability to transport 
metabolites such as bilirubin. Indeed, further investigation 
concerning this phenomenon may provide insight regarding 
the pathophysiology of certain disorders of carbohydrate me- 
tabolism. 
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